Donna M. Gauvin
AbbVie (United States)(US)
Publications by Year
Research Areas
Pain Mechanisms and Treatments, Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Ion Channels and Receptors, Crystallization and Solubility Studies
Most-Cited Works
- → A-803467, a potent and selective Na v 1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat(2007)519 cited
- → A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat(2006)403 cited
- → TRPV1 Receptors in the CNS Play a Key Role in Broad-Spectrum Analgesia of TRPV1 Antagonists(2006)311 cited
- → Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation(2011)269 cited
- → A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel Transient Receptor Potential Type V1 Receptor Antagonist, Relieves Pathophysiological Pain Associated with Inflammation and Tissue Injury in Rats(2005)254 cited
- → P2X7-related modulation of pathological nociception in rats(2007)220 cited
- → Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia(2009)145 cited
- → 3,5-Bis(trifluoromethyl)pyrazoles: A Novel Class of NFAT Transcription Factor Regulator(2000)120 cited
- → Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities(2004)101 cited
- → Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI(2007)97 cited